Your browser doesn't support javascript.
loading
Prohibitin 1 regulates mtDNA release and downstream inflammatory responses.
Liu, Hao; Fan, Hualin; He, Pengcheng; Zhuang, Haixia; Liu, Xiao; Chen, Meiting; Zhong, Wenwei; Zhang, Yi; Zhen, Cien; Li, Yanling; Jiang, Huilin; Meng, Tian; Xu, Yiming; Zhao, Guojun; Feng, Du.
Afiliação
  • Liu H; Qingyuan People's Hospital, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan, China.
  • Fan H; Guangzhou Municipal and Guangdong Provincial Key hLaboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.
  • He P; State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, China.
  • Zhuang H; Guangzhou Municipal and Guangdong Provincial Key hLaboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.
  • Liu X; Department of Cardiology, School of Medicine, South China University of Technology, Guangzhou, China.
  • Chen M; Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Zhong W; Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Zhang Y; Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
  • Zhen C; Department of Cardiology, Heyuan People's Hospital, Heyuan, China.
  • Li Y; Department of Anesthesiology, Second Clinical College of Guangzhou Medical University, Guangzhou, China.
  • Jiang H; Guangzhou Municipal and Guangdong Provincial Key hLaboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.
  • Meng T; Emergency Department, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Xu Y; Guangzhou Municipal and Guangdong Provincial Key hLaboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.
  • Zhao G; Guangzhou Municipal and Guangdong Provincial Key hLaboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.
  • Feng D; GMU-GIBH Joint School of Life Sciences, Guangzhou Medical University, Guangzhou, China.
EMBO J ; 41(24): e111173, 2022 12 15.
Article em En | MEDLINE | ID: mdl-36245295
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: DNA Mitocondrial / Proibitinas Limite: Animals / Humans Idioma: En Revista: EMBO J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: DNA Mitocondrial / Proibitinas Limite: Animals / Humans Idioma: En Revista: EMBO J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China